Search

Author/Creator Drobne, David

11. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study. (27th July 2022)

Authors:
Yanai, Henit; Kagramanova, Anna; Knyazev, Oleg; Sabino, João; Haenen, Shana; Mantzaris, Gerassimos J; Mountaki, Katerina; Armuzzi, Alessandro; Pugliese, Daniela; Furfaro, Federica; Fiorino, Gionata; Drobne, David; Kurent, Tina; Yassin, Sharif; Maharshak, Nitsan; Castiglione, Fabiana; de Sire, Rob...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16:Number 12(2022)
Page Start:
1882
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label. Issue 1 (January 2021)

Authors:
Stefanovic, Sebastian; Detrez, Iris; Compernolle, Griet; Brouwers, Els; Sever, Nejc; Stabuc, Borut; Smrekar, Natasa; Kurent, Tina; Novak, Gregor; Kozelj, Matic; Ferrante, Marc; Gils, Ann; Drobne, David
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 33:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study. Issue 9 (5th June 2017)

Authors:
Kopylov, Uri; Papamichael, Konstantinos; Katsanos, Konstantinos; Waterman, Matti; Bar-Gil Shitrit, Ariella; Boysen, Trine; Portela, Francisco; Peixoto, Armando; Szilagyi, Andrew; Silva, Marco; Maconi, Giovanni; Har-Noy, Ofir; Bossuyt, Peter; Mantzaris, Gerassimos; Barreiro de Acosta, Manuel; Chap...
Journal:
Inflammatory bowel diseases
Issue:
Volume 23:Issue 9(2017)
Page Start:
1605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Optimised infliximab monotherapy is as effective as optimised combination therapy, but is associated with higher drug consumption in inflammatory bowel disease. Issue 7 (19th February 2019)

Authors:
Drobne, David; Kurent, Tina; Golob, Saša; Švegl, Polona; Rajar, Polona; Hanžel, Jurij; Koželj, Matic; Novak, Gregor; Smrekar, Nataša; Ferkolj, Ivan; Štabuc, Borut
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 7(2019)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Success and safety of high infliximab trough levels in inflammatory bowel disease. (3rd August 2018)

Authors:
Drobne, David; Kurent, Tina; Golob, Sasa; Svegl, Polona; Rajar, Polona; Terzic, Sara; Kozelj, Matic; Novak, Gregor; Smrekar, Natasa; Plut, Samo; Sever, Nejc; Strnisa, Luka; Hanzel, Jurij; Brecelj, Jernej; Urlep, Darja; Osredkar, Josko; Homan, Matjaz; Orel, Rok; Stabuc, Borut; Ferkolj, Ivan
Journal:
Scandinavian journal of gastroenterology
Issue:
Volume 53:Number 8(2018)
Page Start:
940
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. (February 2022)

Authors:
Papamichael, Konstantinos; Afif, Waqqas; Drobne, David; Dubinsky, Marla C; Ferrante, Marc; Irving, Peter M; Kamperidis, Nikolaos; Kobayashi, Taku; Kotze, Paulo G; Lambert, Jo; Noor, Nurulamin M; Roblin, Xavier; Roda, Giulia; Vande Casteele, Niels; Yarur, Andres J; Arebi, Naila; Danese, Silvio; Pa...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗